Straxcorp

Straxcorp

Provider of an online medical image analysis software. The company's software analyses CT scans for diagnosis & monitoring of bone health.

  • Edit
Get premium to view all results
DateInvestorsAmountRound
-investor investor

€0.0

round
N/A

€0.0

round
investor

€0.0

round
N/A

€0.0

round
*

N/A

Merger
Total Funding000k
Notes (0)
More about Straxcorp
Made with AI
Edit

Straxcorp was a Melbourne-based Software as a Medical Device (SaMD) company that specialized in developing artificial intelligence and deep learning solutions to improve bone health diagnostics. Founded in 2009, the company developed cloud-based medical software that analyzed CT scans to aid clinicians in diagnosing, monitoring, and assessing fracture risk. The core of its technology was the ability to analyze bone microstructure, which is considered a more direct indicator of bone fragility than bone density alone. The company’s software provided solutions for bone separation, segmentation, and detailed microstructure analysis.

The company was led by Chairman and CEO Gregory Wayne Brown, a healthcare industry veteran with 35 years of experience in medical devices and diagnostics at companies like Baxter Diagnostics, Roche Molecular, and Digene Corp. His extensive background in commercializing medical technologies, including two successful ASX IPOs, guided Straxcorp's strategy. The technical development was overseen by CTO Dr. Yu Peng, who brought 15 years of experience in computer vision and machine learning to the firm.

A pivotal moment in Straxcorp's history was its long-standing collaboration with CurveBeam, LLC, a US-based leader in weight-bearing CT (WBCT) imaging, which began as early as 2017. This partnership led to the adaptation of CurveBeam's InReach cone beam CT scanner to visualize bone microstructure at a high resolution, taking the technology from a research setting to the point-of-care. This collaboration culminated in a merger of equals on October 12, 2022, creating a new entity named CurveBeam AI Limited. The merger integrated Straxcorp's AI and cloud software capabilities with CurveBeam's specialized CT hardware. Greg Brown transitioned to the role of CEO of the newly formed CurveBeam AI. Following the merger, CurveBeam AI successfully listed on the Australian Stock Exchange (ASX:CVB) on August 23, 2023, after raising $25 million in an IPO.

Keywords: Straxcorp, CurveBeam AI, Software as a Medical Device, SaMD, bone health, fracture risk assessment, medical imaging AI, deep learning, CT scan analysis, bone microstructure, bone fragility, cloud-based medical software, Greg Brown, point-of-care diagnostics, weight-bearing CT, Cone Beam CT, ASX:CVB, medical technology, orthopedics, osteoporosis diagnosis, digital health

Analytics
Unlock the full power of analytics with a premium account
Track company size and historic growth
Track team composition and strength
Track website visits and app downloads

Tech stack

Group
Tech stackLearn more about the technologies and tools that this company uses.
Book a Demo

Investments by Straxcorp

Edit